Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting
Open Access
- 12 April 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 7, 84
Abstract
The theory of cancer stem-like cell (or cancer stem cell, CSC) has been established to explain how tumor heterogeneity arises and contributes to tumor progression in diverse cancer types. CSCs are believed to drive tumor growth and elicit resistance to conventional therapeutics. Therefore, CSCs are becoming novel target in both medical researches and clinical studies. Emerging evidences showed that nanoparticles effectively inhibit many types of CSCs by targeting various specific markers (aldehyde dehydrogenases, CD44, CD90, and CD133) and signaling pathways (Notch, Hedgehog, and TGF-β), which are critically involved in CSC function and maintenance. In this review, we briefly summarize the current status of CSC research and review a number of state-of-the-art nanomedicine approaches targeting CSC. In addition, we discuss emerging therapeutic strategies using epigenetic drugs to eliminate CSCs and inhibit cancer cell reprogramming.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 85 references indexed in Scilit:
- The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia modelsLeukemia, 2015
- Editorial (Thematic Issue: Novel Pharmaceutical Approaches by Natural Compound-Derived Epigenetic Regulators: Epigenetic Readers, Writers and Erasers as Therapeutic Targets)Current Topics in Medicinal Chemistry, 2015
- Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathwayNanomedicine: Nanotechnology, Biology and Medicine, 2015
- Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cellsNanomedicine: Nanotechnology, Biology and Medicine, 2015
- PIK3CAH1047R induces multipotency and multi-lineage mammary tumoursNature, 2015
- Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling PathwaysStem Cell Reviews and Reports, 2015
- Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cellsOncology Reports, 2015
- Mechanisms and insights into drug resistance in cancerFrontiers in Pharmacology, 2013
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- Generation of tumor-initiating cells by exogenous delivery of OCT4transcription factorBreast Cancer Research, 2011